MedAI Verdict
Billing & coding

AI Medical Billing

Synthpop logo

Synthpop

by Synthpop  ·  founded 2023  ·  US

Last verified

AI agents for payer eligibility, benefits and authorization checks, plus referral intake for providers.

At a glance

Pricing
No public price. Site CTA is "Book a demo".
HIPAA
Attested
SOC 2
Type II
EHRs
5
Founded
2023
HQ
US
On this page

Independent score  ·  By our public rubric

37/100Competitive

Editorial rating 2.5 / 5

How it’s computed →
  • Regulatory & Compliance
    10/10

    HIPAA + (SOC2 or BAA) attested

  • Clinical Integration
    9.1/31.4

    5 EHR integrations

  • Evidence Strength
    0/10

    No peer-reviewed coverage

  • Vendor & Market
    6/18

    Seed-stage or unfunded

  • Sentiment & Transparency
    3.3/6.5

    Pricing on request, no public amounts

▸ Show all 11 dimensions

Regulatory & Compliance

  • HIPAA / SOC2 / BAA10/10

    HIPAA + (SOC2 or BAA) attested

Clinical Integration

  • EHR integrations (count)9/18

    5 EHR integrations

  • Top-3 EHR coverage (Epic / Oracle / Athena)0/8

    None of the top-3 EHRs covered

  • Bidirectional write-back0/5

    No bidirectional write-back documented

Evidence Strength

  • Peer-reviewed papers0/7

    No peer-reviewed coverage

  • RCT / meta-analysis / systematic review0/3

    No RCT, meta-analysis, or systematic review

Vendor & Market

  • Funding & adoption signal3/12

    Seed-stage or unfunded

  • Years in market3/6

    Founded 2023 (3 years)

Sentiment & Transparency

  • Pricing transparency3/7

    Pricing on request, no public amounts

Scored November 2, 2026 · Public scoring method v1.2.0

AI agents for payer eligibility, benefits and authorization checks, plus referral intake for providers.

No public price. Site CTA is "Book a demo". HIPAA + SOC 2 Type II attested. integrates with Bonafide, NikoHealth, Brightree (and 2 more).

Evidence record

Verification
  • Score computed November 2, 2026, method 1.2.0
  • Review written November 2, 2026
Cite this record

MedAI Verdict, Synthpop record, https://medaiverdict.com/tools/synthpop, version November 2, 2026

Bottom line

Synthpop's homepage pitches its payor agent as a way to "turn hours on hold into verified coverage," checking eligibility, benefits and authorization through APIs first and calling the payor only when nothing else answers. Referral intake, patient outreach and a lab compliance agent sit alongside it. The product handles eligibility, intake and compliance checks and does not code claims. The named systems lean toward DME, home infusion and lab workflows, and no Epic, Oracle or athenahealth appears on the list.

Payor agent and intake

The payor page says results are written back to the customer's system and lists "3 hrs longest payor call handled by AI." Referral and order intake turns "unstructured referral documentation into validated, payor-ready patient orders in under one minute," according to the homepage. Patient engagement over voice and digital channels is credited with handling "~80% manual patient outreach" automatically.

The compliance agent is aimed at pathology labs. It reviews orders against CAP, CLIA, Joint Commission and CMS frameworks and exports source-linked evidence. Prior authorization appears on the site as verification of authorization requirements, and no separate submission feature is described.

Systems it names

The homepage section "Works with your existing systems" is a vendor list. Billing and clearinghouse names are Change Healthcare, Waystar, Experian Health, Availity and R1 RCM. Payor systems are Availity, Optum, Zelis, TriZetto and Change Healthcare. For records and operations it names Bonafide, NikoHealth, Salesforce, Brightree, Practice Fusion and DrChrono.

Funding rounds and reported location

Elad Ferber is CEO and co-founder and Jan Jannink, PhD, is CTO and co-founder, with 2023 as the founding year. Tracxn and Caplight list Cambridge, Massachusetts, and an older article called the company NYC based. HQ is not confirmed on an official page.

HLTH reported a US$15M Series A led by Ansa Capital on February 4, 2026, with Defy.vc, Peterson Ventures and Storm Ventures, bringing the total to about US$23M. Tracxn shows $25.8M. An earlier US$5.6M seed was led by Peterson Ventures.

Outcome claims and security wording

The homepage claims "9M+ patients supported," "96% faster processing," a "5x order-to-cash improvement," "58% fewer manual payor calls," "~2x faster time to therapy" and "$8 to $16 saved per patient," with no method given. The payor and compliance pages say "HIPAA, SOC 2, and full audit trails on every verification attempt" and "HIPAA-compliant, SOC 2-audited ... running inside your own environment," with badges for "HIPAA Compliant" and "SOC 2 Certified." The SOC 2 type is not given.

An open source R package for synthetic data shares the name. A PubMed search for "Synthpop" returns 15 hits, and the first five titles all concern that package.

Where does a price come from?

The site has no pricing page. "Book a demo" is the route to a quote.

The verdict

Revenue cycle teams in DME, infusion and lab settings that lose hours to payor calls match the profile the homepage and its system list describe. A hospital on Epic, or a buyer who needs the SOC 2 type before shortlisting, would have to ask Synthpop for what the site does not say. Under "Trusted by" the homepage shows one customer, MedBridge.

Editorial review last generated November 2, 2026. Synthesized from clinician sentiment, peer-reviewed coverage, and our editorial silo picks. Refined by hand where vendor facts change.

What it costs

All tiers are custom-quoted. The vendor does not publish per-provider list pricing.

TierMonthlyAnnualNotes
EnterpriseNot statedNot statedNo public price. Site CTA is "Book a demo".

Source: vendor pricing page. Last checked November 2, 2026.

What deploys cleanly

Carries HIPAA, SOC 2 per vendor documentation. Independent attestation review is the buyer's responsibility before clinical deployment. Integrates with 5 EHRs: Bonafide, NikoHealth, Brightree, Practice Fusion, DrChrono.

Who builds it

Synthpop (Synthpop) was founded in 2023 in US, putting it 3 years into market.